This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Direct Thrombin Inhibitors in ACS and AMI: From ACUITY to HORIZONS
* Antithrombin Choices for PCI, ACS, and AMI
* Bivalirudin
* Overcoming Limitations of Heparins
* Heparin Aggregates Platelets in ACS
* Bivalirudin Antiplatelet Effect
* REPLACE: Bivalirudin vs Heparin + GPI During PCI
* REPLACE 30-d 1 Endpoint
* Bleeding Complications
* Mortality at 1 Year
|
|